Subscriber Content Preview | Request a free trialSearch  
  Go

Knowledge Centers

A Look Under the Microscope: The JOBS Act's Impact on Private Equity

JOBS_680x200.gifJOBSAct-SlideShowFinal.ppt
July 26, 2012 - 2 p.m. EST

The Obama administration's attempt to jump-start the economy has had its ebbs and flows. One of the government's latest strategies to stimulate growth is the passing in April of the Jumpstart Our Business Startups Act. While the new mandate sounds ambitious, what does it mean for the world of private equity and dealmaking? Join The Deal LLC's senior writer David Marcus for this webcast as he moderates a panel of experts to evaluate the JOBS Act. The panel will put the law into context and look at how it will impact the bottom line of private equity firms and their initial public offerings, exits and fundraisings.

The webcast will also explore the main ingredients of the law, such as the ease of restrictions on certain issuers' ability to partake in "general solicitation or general advertising" in connection with private financings and the streamlining of the IPO process for emerging-growth companies.

After just 60 minutes, you'll have a refreshed perspective on the possible directions this market will take and be better placed to plot the course for your business over the next six to 12 months. Register today and we'll be sure to remind you when the webcast takes place and when the on-demand replay is available. We look forward to you joining us from your desk.

Moderator:

Marcus_David_153x153.gifDavid Marcus
Senior writer
The Deal LLC

David Marcus focuses on legal issues raised by corporate transactions. He writes about the structure of merger agreements, Delaware law cases and developments, and cross-border M&A. He also regularly writes profiles of M&A lawyers and bankers.

Marcus has been a reporter at The Deal LLC since its launch in 1999. He has also been the senior writer on Corporate Control Alert -- The Deal's journal of legal and financial trends in dealmaking -- since 1997.

Expert panelists:

Maierson, Ryan_153.jpgRyan Maierson
Partner
Latham & Watkins LLP

Ryan J. Maierson is a partner in the Houston office, where he specializes in corporate transactions in the energy industry, with an emphasis on master limited partnerships. Maierson's practice focuses on:


  • Mergers and acquisitions
  • Representing issuers and underwriters in securities offerings
  • Representing both sponsors and portfolio companies in private equity transactions
  • Corporate governance
He is an adjunct professor at the University of Houston Law Center, where he co-teaches "Doing Deals," a course on M&A practice, with Professor Douglas Moll.

Andrea_Auerbach_153.jpgAndrea Auerbach
Managing director & head U.S. private equity research,
Cambridge Associates

Auerbach is a managing director at Cambridge Associates in the Boston office. She heads the U.S. private equity research team, which performs due diligence on investment opportunities in private equity, mezzanine, and distressed markets. Her responsibilities include visiting investment firms and sometimes their portfolio companies and tracking the industry. Auerbach and her team also advise the firm's investment consultants on new and existing firms raising and managing funds.

Prior to joining Cambridge Associates in 2001, she was a senior director at Prudential Private Equity. Over the course of her eight years with Prudential in New Jersey, New York, and London, Andrea invested and managed over $1 billion of capital in U.S. buyouts, venture capital, real estate, and European mezzanine and private equity. She also led early efforts to benchmark Prudential's $5 billion buyout portfolio, and domestic and European fund investment portfolios. Auerbach was also an equity research associate focused on technology at Harris Nesbitt Gerard.Auerbach earned an M.B.A. from Harvard Business School and a B.A. in economics from Smith College.


Jorge Mora_153x153.jpgJorge Mora
U.S. head of financial sponsors
Macquarie Capital

Jorge Mora has been involved in a number of significant transactions throughout his career, notably: advising Blackstone and One Equity Partners on their Travelport acquisition; Rowland Coffee on its recent sale to Smuckers; the selling shareholders in Net-a-Porter to Richemont; Providence in its acquisition of the Clear Channel Television assets; Rhone Group in its acquisition of LWB and subsequent merger with Magnesita; Court Square Capital on their SGS and Western Dental acquisition; Towerbrook on their spin-off fundraising from Soros; and Kelso in its acquisition of ADESA.

Prior to joining Macquarie Capital, Mora was head of the financial sponsors business at Lazard.  Prior to that, he spent over eight years with UBS as a managing director in their financial sponsors group, where he closed more than 100 transactions with over a dozen private equity groups spanning a variety of sectors including technology, media, energy, industrials and health care.  He was a top global revenue producer for UBS, bringing in over $350 million in fees between 2005 and 2008.  He has held roles with The Exxel Group, a Latin America private equity group based in Buenos Aires, and at Donaldson, Lufkin & Jenrette in their mergers & acquisitions group. 

Mora received his M.B.A from from The Wharton School at the University of Pennsylvania and his B.B.A from University of Miami. 

Dinan_MIke_152x153.jpgMike Dinan
CEO & president
Dinan & Co. LLC

Prior to founding Dinan & Company in 1988, Dinan was employed by Young, Smith & Peacock  Inc., a NYSE member investment banking and brokerage firm, as vice president - corporate finance in its investment banking division, where he was involved in mergers and acquisitions, private placements, valuation analyses and other securities-related transactions.

Dinan also worked for Angerman Incorporated, a West German investment banking firm, specializing in cross-border mergers and acquisitions.

Dinan holds a bachelor of science, magna cum laude, in both Economics and International Business from Arizona State University. He currently holds Series 24, 79, 99 and 63 securities licenses.




Presented by